IP Library › Granted Patent US 12,606,584
Granted Patent B2
US 12,606,584 · App. 17/617,819 · Granted Apr 21, 2026

Process for the preparation of oligonucleotides using modified oxidation protocol

Inventors: Alec Fettes (Maur, CH); Achim Geiser (Seon, CH); Leonhard Jaitz (Oeschgen, CH); Hongrim Choi (Seoul, KR); Kyeong Eun Jung (Seoul, KR); Sung Won Kim (Seoul, KR)
Assignee: HOFFMANN-LA ROCHE INC.
C07H1/00C07H21/02C07H21/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,606,584
App. No.
17/617,819
Granted
Apr 21, 2026
Kind
B2
Abstract

The invention relates to a process for the production of a mixed P═O/P═S backbone oligonucleotide comprising a selective oxidation of an intermediary phosphite triester compound of formula I into a phosphodiester compound of formula II according to the scheme with an oxidation solution obtained by mixing iodine, an organic solvent and water, characterized in that the oxidation solution has been aged for a time period that is sufficient to selectively oxidize the phosphite triester compound of formula I into the phosphodiester compound of formula II without oxidizing the phosphorothioate internucleotide linkages.

Claims (14)

1 . A process of selectively oxidizing an intermediary phosphite triester in a mixed phosphodiester/phosphorothioate backbone oligonucleotide comprising:

preparing an oxidation solution comprising iodine, pyridine and water;

aging the oxidation solution for 1 day to 30 days at a temperature of 60° C. to 65° C. to produce an aged oxidation solution; and

oxidizing an intermediary phosphite triester compound of formula I with the aged oxidation solution, thereby forming a phosphodiester compound of formula II according to the scheme

wherein the 3′ and/or 5′ nucleoside residue comprises at least one phosphorothioate internucleotide linkage.

2 . The method of claim 1 , wherein the oxidation solution is aged for 2 days to 15 days at a temperature of 60° C. to 65° C. to produce an aged oxidation solution.

3 . The method of claim 1 , wherein the volume ratio of pyridine to water is from 1:1 to 20:1.

4 . The method of claim 1 , wherein the iodine concentration in the oxidation solution is 10 mM to 100 mM.

5 . The method of claim 1 , wherein the reaction temperature for the oxidizing step is selected between 15° C. and 27° C.

6 . The method of claim 1 , wherein the oligonucleotide consists of optionally modified DNA or RNA nucleoside monomers or combinations thereof and is 10 to 40 nucleotides in length.

7 . The method of claim 3 , wherein the volume ratio of pyridine to water is from 5:1 to 15:1.

8 . The method of claim 3 , wherein the volume ratio of pyridine to water is 9:1.

9 . The method of claim 4 , wherein the iodine concentration in the oxidation solution is 20 mM to 50 mM.

10 . The method of claim 6 , wherein the oligonucleotide consists of optionally modified DNA or RNA nucleoside monomers or combinations thereof and is 10 to 25 nucleotides in length.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2023
From: CHOI, HONGRIM; JUNG, KYEONG EUN; KIM, SUNG WON
To: ST PHARM CO., LTD.
Reel/Frame 063873/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: FETTES, ALEC; JAITZ, LEONHARD; GEISER, ACHIM
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 063801/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 063801/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 063801/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: ST PHARM CO., LTD.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 063804/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: CHOI, HONGRIM; JUNG, KYEONG EUN; KIM, SUNG WON
To: ST PHARM CO., LTD.
Reel/Frame 065018/0613 →
Priority Claims (1)
EP 19179310 · Jun 11, 2019 · regional
Continuity (1)
Related Publication 20230295207A1 · Sep 21, 2023
References Cited (31)
US 5631362A · Pfleiderer et al. · 1997 [cited by applicant]
US 7205399B1 · Vargeese et al. · 2007 [cited by applicant]
US 20040024194A1 · Ravikumar · 2004 [cited by applicant]
US 20220251128A1 · McPherson · 2022 [cited by examiner]
CN 103298823A · 2013 [cited by applicant]
CN 107474091A · 2017 [cited by applicant]
CN 109641932A · 2019 [cited by applicant]
JP H05320122 · 1993 [cited by applicant]
JP 2002536453A · 2002 [cited by applicant]
JP 2004533488A · 2004 [cited by applicant]
KR 1019990022711 · 1999 [cited by applicant]
WO 96040708A2 · 1996 [cited by applicant]
WO 97019092A1 · 1997 [cited by applicant]
WO 99018238 · 1999 [cited by applicant]
WO 00047593A1 · 2000 [cited by applicant]
WO 03004512A1 · 2003 [cited by applicant]
WO 2007097446A1 · 2007 [cited by applicant]
WO 2012001126A1 · 2012 [cited by applicant]
WO 2013134686A1 · 2013 [cited by applicant]
WO 2018019799A2 · 2018 [cited by applicant]
WO 2018197533A1 · 2018 [cited by applicant]
WO 2020236618A1 · 2020 [cited by applicant]
Beaucage, S., et al., “The synthesis of modified oligonucleotides by the phosphoramidite approach and their applications” Tetrahedron 49(28):6123-6194 (Jul. 9, 1993). [cited by applicant]
Grevys, A., et al., “A human endothelial cell-based recycling assay for screening of FcRn targeted molecules” Nat Commun 9(1):621 (1-14) (Feb. 12, 2018). [cited by applicant]
“International Preliminary Report on Patentability—PCT/EP2020/065992” (Report Issuance Date: Dec. 14, 2021; Chapter I), :pp. 1-8 (Dec. 23, 2021). [cited by applicant]
“International Search Report—PCT/EP2020/065992” (w/Written Opinion),: pp. 1-17 (Jul. 3, 2020). [cited by applicant]
Nath, N., et al., “Homogeneous plate based antibody internalization assay using pH sensor fluorescent dye” J Immunol Methods 431:11-21 (Apr. 1, 2016). [cited by applicant]
“Safety Data Sheet, Product Name: Oxidizing Reagent 0.05 M Iodine in Pyridine / Water 90/10b (vv) for DNA Synthesis Novabiochem®, Catalog No. BI0424,” Sigma-Aldrich Japan, pp. 15 (Read on Apr. 19, 2023). [cited by applicant]
Oxidizing Reagent, 0.05M, I [cited by applicant]
Sato et al., Wakou Jun'yaku jihou 86(4):12-13 (Oct. 2018). [cited by applicant]
Wei et al., “Coupling activators for the oligonucleotide synthesis via phosphoramidite approach” Tetrahedron 69:3615-3637 ( 2013). [cited by applicant]